Ronald Kirk Huntsman's Net Worth
$345 Thousand
Who is Ronald Kirk Huntsman?
Ronald Kirk Huntsman does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Vivos Therapeutics, Inc..
SEC CIK
Ronald Kirk Huntsman's CIK is 0001835498
Past Insider Trading and Trends
2022 was Ronald Kirk Huntsman's most active year for acquiring shares with 6 total transactions. Ronald Kirk Huntsman's most active month to acquire stocks was the month of May. 2022 saw Ronald Kirk Huntsman paying a total of $674,310.32 for 640,334 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vivos Therapeutics, Inc. (VVOS) Snapshot price: $5.42
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +19.30% | 14K |
$0.53 | $7,420.00 | 86.52K |
Jun 20
| |||
Form 4
| +26.12% | 15.02K |
$0.54 | $8,060.50 | 72.52K |
Jun 15 - Jun 16
| |||
Form 4
| +21.05% | 10K |
$0.49 | $4,900.00 | 57.5K |
Jun 14
| |||
Form 4
| +72.73% | 20K |
$0.50 | $10,000.00 | 47.5K |
Dec 23
| |||
Form 4
| +77.42% | 12K |
$1.96 | $23,560.00 | 27.5K |
May 31 - Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
| +47.62% | 5K |
$4.31 | $21,550.00 | 15.5K |
Sep 21
| |||
Form 4
| +90.91% | 5K |
$3.00 | $15,000.00 | 10.5K |
Aug 17
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +266.67% | 4K |
$5.38 | $21,520.00 | 5.5K |
May 25
| |||
Form 4
| +200.00% | 1K |
$7.27 | $7,266.90 | 1.5K |
Dec 23
| |||
Form 4
|
∞
| 500 |
$8.50 | $4,250.00 | 500 |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||